`
`
`By: Jeffrey D. Blake, Esq.
` MERCHANT & GOULD P.C.
`
`191 Peachtree Street N.E., Suite 4300
` Atlanta, GA 30303
`
`jblake@merchantgould.com
` Main Telephone: (404) 954-5100
` Main Facsimile: (404) 954-5099
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`___________________
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`___________________
`
`
`COALITION FOR AFFORDABLE DRUGS X LLC,
`Petitioner,
`
`v.
`
`
`ANACOR PHARMACEUTICALS, INC.,
`Patent Owner.
`___________________
`
`Case No.: 2015-01776
`Patent No.: 7,582,621
`________________________________________________________
`
`SUPPLEMENTAL DECLARATION OF S. NARASIMHA MURTHY PH.D.
`IN SUPPORT OF PETITIONER’S SUPPLEMENTAL EVIDENCE AND
`RESPONSE TO PATENT OWNER’S OBJECTIONS TO THE PETITION
`EVIDENCE PURSUANT TO 37 C.F.R. § 42.64
`
`CFAD Exhibit 1042
`
`
`
`
`
`
`
`Supplemental Declaration of S. Narasimha Murthy, Ph.D.
`Inter Partes Review of Patent No. 7,582,621
`IPR2015-01776
`
`I, S. Narasimha Murthy, Ph.D., hereby state the following:
`
`1.
`
`I am providing this supplemental declaration in support of the
`
`Petition For Inter Partes Review of Patent No. 7,582,621 and in support of the
`
`reply to Patent Owner’s Objections To Petitioner’s Evidence Under 37 C.F.R. §
`
`42.64(b)(1).
`
`2.
`
`I previously provided a declaration dated June 15, 2015, as part of the
`
`petition filed by Coalition for Affordable Drugs X LLC. My previous declaration is
`
`Ex. 1008.
`
`3.
`
`I am competent to make this declaration based upon my personal
`
`knowledge and technical expertise, which I addressed in my first declaration, dated
`
`June 15, 2015.
`
`4.
`
`I understand that Patent Owner has raised evidentiary objections to
`
`Exhibit 1024 (BioborJF® Specification Sheet) and Exhibit 1025 (BioborJF®
`
`MSDS). I have previously considered these exhibits in preparation of my previous
`
`declaration. (Ex. 1008.)
`
`5.
`
`It is my understanding that the Petitioner is submitting supplemental
`
`exhibits as part of its response to Patent Owner’s objections to Exhibit 1024 and
`
`Exhibit 1025.
`
`6.
`
`It is my understanding the new exhibits are Exhibit 1037 and Exhibit
`
`
`
`2
`
`
`
`Supplemental Declaration of S. Narasimha Murthy, Ph_D_
`Inter Partes Review of Patent No. 7,582,621
`IPR2015—0l776
`
`1038. It is my understanding the Petitioner is serving Exhibit 1037 in response to
`
`Patent Owner’s objections to Exhibit 1024 and serving Exhibit 1038 in response to
`
`Patent Owner’s objections to Exhibit 1025.
`
`7.
`
`All the exhibits I have considered and relied on in this proceeding
`
`(including the supplemental exhibits) are the kinds of documents I typically rely on
`
`when fomiing opinions, such as the opinions I offer in this proceeding.
`
`8.
`
`I have considered Exhibit 1037 and Exhibit 1038.
`
`EXHIBIT
`
`DESCRIPTION
`
`FILED
`
`Biobor, R.E.D. Facts, EPA—738—R—93—004 (June 1993),
`http://nepis_epa_gov/Exe/ZyPDF.cgi?Dockey=200009P5.P
`DF
`
`BioborJF®
`
`Excerpts From The Certified Prosecution History For U.S.
`Patent No- 6,878,365, Including The MSDS Sheet For
`
`9.
`
`It is my understanding that Exhibit 1037 is a report from the United
`
`States Environmental Protection Agency concerning Biobor and entitled R.E.D.
`
`Facts. Like Ex. 1024, Ex. 1037 discloses that Biobor is a fungicide used in the fuel
`
`tanks and fuel lines of vehicles to prevent the growth of microbial organisms and
`
`that Biobor was initially registered in the United States in 1965.
`
`10. My consideration of Exhibit 1037 does not change my opinions set
`
`forth in my previous declaration (Ex. 1008).
`
`
`
`Supplemental Declaration of S. Narasimha Murthy, Ph.D.
`Inter Partes Review of Patent No. 7,582,621
`IPR2015-01776
`
`
`11.
`
`It is my understanding that Exhibit 1038 is the BioborJF® MSDS
`
`from the certified prosecution history of U.S. Patent No. 6,878,365 to Brehove.
`
`Exhibit 1038 appears to be the same MSDS sheet that I previously considered as
`
`Exhibit 1025 but with an earlier publication date.
`
`12. My consideration of Exhibit 1038 does not change my opinions set
`
`forth in my previous declaration (Ex. 1008).
`
`13.
`
`In signing this Declaration, I understand that it will be filed as
`
`evidence in a contested case before the Patent Trial and Appeal Board of the
`
`USPTO. I acknowledge that I may be subject to cross-examination in the case and
`
`that cross-examination will take place within the United States. If cross-
`
`examination is required of me, I will appear for cross-examination within the
`
`United States during the time allotted for cross-examination.
`
`14.
`
` I hereby declare that all statements made herein of my own
`
`knowledge are true and that all statements made on information and belief are
`
`believed to be true; and that these statements were made with the knowledge that
`
`willful false statements and the like so made are punishable by fine or
`
`imprisonment, or both, under Section 1001 of Title 18 of the United States Code.
`
`
`
`
`
`
`
`4
`
`
`
`Supplemental Declaration of S. Narasimha Murthy, Ph.D.
`Inter Partes Review of Patent No. 7,582,621
`IPR2015-01776
`
`Dated:
`
`April_5_, 2016
`
`
`
`
`
`________________________
`S. Narasimha Murthy, Ph.D.
`
`
`
`
`5